Evidence map›Paper›PMID 34802431›Full record

Observational studyBMC pulmonary medicine2021

The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea.

Lu Yan, Zhihui Zhao, Qing Zhao, Qi Jin, Yi Zhang, Xin Li, Anqi Duan, Qin Luo, Zhihong Liu

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC pulmonary medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lu YanCenter for Pulmonary Vascular Diseases, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 BeiLiShi Road, Xicheng District, Beijing, 100037, China.
Zhihui ZhaoCenter for Pulmonary Vascular Diseases, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 BeiLiShi Road, Xicheng District, Beijing, 100037, China.
Qing ZhaoCenter for Pulmonary Vascular Diseases, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 BeiLiShi Road, Xicheng District, Beijing, 100037, China.
Qi JinCenter for Pulmonary Vascular Diseases, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 BeiLiShi Road, Xicheng District, Beijing, 100037, China.
Yi ZhangCenter for Pulmonary Vascular Diseases, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 BeiLiShi Road, Xicheng District, Beijing, 100037, China.
Xin LiCenter for Pulmonary Vascular Diseases, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 BeiLiShi Road, Xicheng District, Beijing, 100037, China.
Anqi DuanCenter for Pulmonary Vascular Diseases, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 BeiLiShi Road, Xicheng District, Beijing, 100037, China.
Qin LuoCenter for Pulmonary Vascular Diseases, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 BeiLiShi Road, Xicheng District, Beijing, 100037, China. luoqin2009@163.com.
Zhihong LiuCenter for Pulmonary Vascular Diseases, Fuwai Hospital, National Clinical Research Center for Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 BeiLiShi Road, Xicheng District, Beijing, 100037, China. zhihongliufuwai@163.com.
Chinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

Beijing Municipal Science and Technology Project Z181100001718200
6 · The paper itself

Abstract

objectiveObstructive sleep apnoea (OSA) is one cause of pulmonary hypertension (PH) and can also emerge along with PH. The clinical diagnosis and treatment of OSA in patients with PH are still controversial. The purpose of this clinical observation study was to observe and summarize the incidence and clinical characteristics of OSA in patients with PH and to explore possible predictors of PH combined with OSA.

methodsPatients with PH diagnosed by right heart catheterization who underwent overnight cardiorespiratory monitoring from December 2018 to December 2020 were enrolled. OSA was defined as an apnoea-hypopnoea index of ≥ 5/h with ≥ 50% of apnoeic events being obstructive. Baseline clinical characteristics and parameters were collected to compare PH patients with and without OSA. Logistic regression analysis was run to determine the risk factors for OSA in PH patients.

resultsA total of 35 (25%) of 140 patients had OSA. OSA is relatively frequent in patients with PH, especially in patients with chronic thromboembolic pulmonary hypertension and patients with lung disease- or hypoxia-associated PH. The patients who had OSA were mostly male and had a higher age and a lower daytime arterial oxygen pressure. Logistic regression analysis found that older age, male sex, and lower daytime arterial blood oxygen pressure correlated with OSA in PH patients.

conclusionOSA is common in patients with PH. Lower daytime arterial oxygen pressure is a risk factor for OSA in older male patients with PH.

Indexed as

AdultCase-Control StudiesFemaleHumansHypertension, PulmonaryIncidenceLogistic ModelsMaleMiddle AgedProspective StudiesRisk FactorsSleep Apnea, ObstructiveObstructive sleep apnoeaPulmonary hypertensionRisk factors

Identifiers

PMID34802431
PMCPMC8607599
OpenAlexW3215236587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.